Colgate-Palmolive Company
CL
NYSE·Consumer Defensive·Household & Personal Products·Mkt cap $71.0B
$88.77
▼ -1.47%
P/E
35.03
Mkt Cap
$71.0B
52-Wk Range
$74.55–$99.33
52-Week Range
$74.55 - $99.33
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 5.4% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Strong global brand recognition
- Extensive distribution network
- Diversified product portfolio
- Long-standing consumer trust
Bear Case
2 risks
- Low volatility (beta 0.3).
- Premium valuation to Household Products peers
Growth
Stable outlook
Emerging market expansion
Value
Premium valuation to Household Products peers
Momentum
Stable
+3.1% over 3m
Quality
Excellent
Strong fundamentals
Dividend
Solid
2.37% yield
Smart-money signal
Who's buying CL right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Oct 30, 2026
JUL 31, 2026
Reported EPS of $0.99 vs $0.95 consensus (+4.5% surprise). Revenue of $5.4B vs $5.4B expected (+0.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+4.5%
Revenue trend · last 8Q
—
-0%
-3%
+1%
+2%
+6%
+8%
+5%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$5.0B
$4.9B
$4.9B
$5.1B
$5.1B
$5.2B
$5.3B
$5.4B
Margins · last 8Q
Gross
61.5%
Operating
18.9%
Profit
12.9%
Wall Street consensus
13 analysts · 69% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
69%
Hold
31%
Sell
0%
Median Price Target
—
Latest: Jefferies · Aug 3, 2026
vs Industry
How CL stacks vs Household & Personal Products
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related